Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample	Treatment
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.5697	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.5697	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.6030	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.6363	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.6843	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.8597	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	0.9348	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	1.0652	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	1.4763	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	1.5074	Peak area	Feces	Angiotensin II
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	1.9840	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	2.5180	Peak area	Feces	Saline
Reversed phase NEGATIVE ION MODE	phenylacetylglutamine	2.9729	Peak area	Feces	Angiotensin II